In human lung cancer cells, interferon regulatory factor 1 (IRF1) binds to the putative binding sequence in PD-L1 promoter region and induces the transcription depending on JAL/STAT pathway response to IFNγ (17). The gene discussed is IRF1; the disease is lung carcinoma.